Evidence map›Paper›PMID 38411169›Full record

ArticleeLife2024

Control of meiotic entry by dual inhibition of a key mitotic transcription factor.

Amanda J Su, Siri C Yendluri, Elçin Ünal

Open access · goldAbstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Amanda J SuDepartment of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States.ORCID https://orcid.org/0009-0002-4203-1713
Siri C YendluriDepartment of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States.
Elçin ÜnalDepartment of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States.ORCID https://orcid.org/0000-0002-6768-609X
University of California, Berkeley · US

Funding

THE MOLECULAR BASIS OF CELL FUNCTIONT32GM007232 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI BILDER, DAVID, UNAL, ELCIN · 1985 to 2022
$36.4M
Developmental Regulation of Gene Expression by Long Undecoded Transcript IsoformsR01GM140005 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI UNAL, ELCIN · 2021 to 2024
$1.3M
NIGMS NIH HHS R01 GM140005NIGMS NIH HHS T32 GM007232NIH HHS R01 GM140005NIH HHS T32 GM007232
6 · The paper itself

Abstract

The mitosis to meiosis transition requires dynamic changes in gene expression, but whether and how the mitotic transcriptional machinery is regulated during this transition is unknown. In budding yeast, SBF and MBF transcription factors initiate the mitotic gene expression program. Here, we report two mechanisms that work together to restrict SBF activity during meiotic entry: repression of the SBF-specific Swi4 subunit through LUTI-based regulation and inhibition of SBF by Whi5, a functional homolog of the Rb tumor suppressor. We find that untimely SBF activation causes downregulation of early meiotic genes and delays meiotic entry. These defects are largely driven by the SBF-target G1 cyclins, which block the interaction between the central meiotic regulator Ime1 and its cofactor Ume6. Our study provides insight into the role of

Indexed as

Saccharomyces cerevisiae ProteinsTranscription FactorsG1 PhaseGene Expression Regulation, FungalMeiosisPromoter Regions, GeneticRepressor ProteinsSaccharomyces cerevisiaeRepressor ProteinsSaccharomyces cerevisiae ProteinsTranscription FactorsWhi5 protein, S cerevisiaecell cyclechromosomesgene expressionLUTImeiosismitosisS. cerevisiaetranscription factoruORF

Identifiers

PMID38411169
PMCPMC10939502
OpenAlexW4386897040

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.